Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Series D

SQZ sequences $65m series D
20th May 2020
Thierry Heles
GV and Illumina Ventures returned to reinvest in cellular therapy developer SQZ Biotechnologies, an MIT spinout that has now raised at least $166m to date.
New Horizon brings $20m series D
23rd April 2020
Robert Lavine
Dumac contributed to a round that took the total raised by the cancer screening system developer past the $130m mark.
Reflexion radios in for another $100m
17th April 2020
Robert Lavine
The radiotherapy developer, which is exploiting UChicago research, has now raised $264m in funding overall.
Graphcore grows series D to $350m
25th February 2020
Thierry Heles
Graphcore, which traces its origins back to University of Bristol, has added $150m to a round that already included Ahren Innovation Capital.
Verana charts course to $100m
6th February 2020
Thierry Heles
Oak Ridge spinout Verana Health has completed a $100m round led by existing investor GV that will help it expand its clinical database platform into new areas.
Promethera protracts series D round
18th December 2019
Callum Cyrus
Medipal and Sony Innovation Fund by IGV were among the investors that boosted the liver disease drug spinout's latest round to $52.6m.
Inscripta cribs $125m in series D round
18th December 2019
Thierry Heles
CU Boulder spinout Inscripta has now accumulated more than $259m from investors including Institut Mérieux, and will use the capital to further expand its genome engineering platform.
Sera Prognostics diagnoses $36m series D
14th November 2019
Thierry Heles
Based on research from Brigham Young University and University of Utah, Sera has added $36m to its funding vault to drive commercialisation of its blood testing system PreTRM.

Other News

EpicentRx rustles up $35m
14th November 2019
Callum Cyrus
Building on UCSD intellectual property, EpicentRx is working on immunotherapy drugs intended to target the body's non-specific and adaptive specific immune function synchronously.
Casiris clears up $19.1m
16th September 2019
Callum Cyrus
Laser project technology company Casiris Technology lured Cash Capital and Cas Star to the table for its series D-plus round.
Cogito coaxes $20m out of investors
10th September 2019
Callum Cyrus
Sales team-focused voice analytics software developer Cogito, an MIT spinout, attracted investors including Salesforce, New York Life and Goldman Sachs to bring its overall total to $100m.
Menlo Security decrypts $75m series D
10th July 2019
Callum Cyrus
Building on UC Berkeley research, cybersecurity software company Menlo Security has now raised approximately $150m altogether.
Oxford PV locks in series D close
5th July 2019
Robert Lavine
University of Oxford's solar cell technology developer Oxford PV has closed a series D round featuring Meyer Burger, Equinor and Legal & General at $81.8m.
Lundbeck signs up for Sanifit’s series D
28th June 2019
Callum Cyrus
University of the Balearic Islands spinout Sanifit has raised $62.8m in a series D round backed by existing backer Lundbeckfonden Ventures to bring its overall financing to $149m.

Editor's Picks

Big deal: Oxford PV begins capturing series D
18th March 2019
Thierry Heles
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
© 2020 Mawsonia Ltd. All rights reserved.
test reg

Login

Forgot password?

Not yet subscribed?

See your subscription offers here